TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $799,753 | -4.9% | 51,697 | -3.4% | 0.01% | 0.0% |
| Q2 2023 | $840,595 | -4.0% | 53,507 | +0.7% | 0.01% | -9.1% |
| Q1 2023 | $875,335 | -47.0% | 53,115 | -49.8% | 0.01% | 0.0% |
| Q4 2022 | $1,650,324 | +140.6% | 105,790 | +100.0% | 0.01% | +10.0% |
| Q3 2022 | $686,000 | +0.4% | 52,895 | +8.7% | 0.01% | +11.1% |
| Q2 2022 | $683,000 | -2.7% | 48,665 | -0.7% | 0.01% | +12.5% |
| Q1 2022 | $702,000 | +5.1% | 49,010 | 0.0% | 0.01% | +14.3% |
| Q4 2021 | $668,000 | – | 49,010 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |